Dr. Charlie Gersbach — Editing the Human Genome and Epigenome with the CRISPR/Cas9 System to Correct Genetic Disease and Program Cell Phenotype
Starts: 10:00 am
Ends: October 20, 2014 - 11:00 am
Location: GBSF 1005
Description: Dr. Gersbach (Duke University) is a leader in genome engineering. He is the 2014 recipient of the Outstanding Young Investigator Award by the American Society for Gene and Cell Therapy (ASGCT), largely for this work with Duchenne Muscular Dystrophy.